Back
to sessions
Sep 29
Scientific
MODERATOR(S)
Giuseppe Minniti, MD, PhD - Università di Roma Sapienza
Aaron Simon, MD, PhD - UC Irvine Health
Credits
| AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
02:15pm - 02:25pm ET
Connectome-Informed Cognition-Sparing Stereotactic Brain Radiosurgery: Comparison of Cognitive Outcomes to Historical Controls
Speaker: Andrew Puett, MD, PhD - UC San Diego Radiation Medicine and Applied Sciences, La Jolla -
02:25pm - 02:35pm ET
Upfront Local Therapy in Melanoma Brain Metastases Treated with Ipilimumab-Nivolumab: An International Multicenter Analysis of Immunotherapy-Naïve Patients
Speaker: James Lee, - Memorial Sloan Kettering Cancer Center, Middletown Township -
02:35pm - 02:45pm ET
Prospective Neurocognitive Outcomes in Patients with 5 to 30 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial
Speaker: Chia-Lin Tseng, MD - Sunnybrook Health Sciences Centre, Toronto -
02:45pm - 02:55pm ETSpeaker: Tina Vaziri, MD - Johns Hopkins Hospital, Baltimore
-
02:55pm - 03:05pm ET
Clinicogenomic Risk Stratification Identifies Metastatic Breast Cancer Patients at High Risk for Symptomatic Brain Metastases
Speaker: Luke Pike, MD, DPhil - Memorial Sloan Kettering Cancer Center, New York -
03:05pm - 03:15pm ET
Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases: A Single-Center, Single Arm, Phase II Trial
Speaker: Yuchao Ma, MD - Cancer Institute & Hospital Chinese Acedemy of Medical Sciences, Beijing -
03:15pm - 03:25pm ETSpeaker: Minesh Mehta, MD, MB, ChB, FASTRO - Miami Cancer Institute- Baptist Health South Florida, Miami